Trusted Partner in Calprotectin Testing
Smart, connected IBD Diagnostics and monitoring trusted worldwide for 30+ years.
Delivering Prognostic Insight Across the IBD Care Pathway
Calpro provides clinically validated calprotectin solutions that support faster, more reliable IBD monitoring. From rapid home testing to clinic‑based point‑of‑care monitoring and laboratory ELISA kits, our portfolio helps clinicians and patients make timely, informed decisions that can support reductions in unnecessary procedures and contribute to improved outcomes.
Rapid Self-Test & Point-of-Care Test
Quick and reliable calprotectin tests for home and point-of-care, with results in minutes
Laboratory Assays
High-precision calprotectin assays for accurate IBD diagnosis and monitoring
Extraction Device
Easy and hygienic stool sample preparation for dependable calprotectin testing
Our complete portfolio
Calprotectin Solutions
– From Lab to Home
We deliver total solution for calprotectin diagnostics and monitoring tools: CalproLab® ELISA and RUO kits with Calpro Easy Extract® devices for laboratories, CalproSmart® Office + app for point-of-care use providing quantitative results in under 20 minutes, and CalproSmart® Self-Test for home monitoring with clinician connectivity.
Secure API and DeepLink integrations connect CalproSmart® data to HIS and LIMS platforms and apps, enabling real time data that can be combined with patient reported outcome measures to support IBD programs throughout Europe.
Evidence-based biomarker
Why Calprotectin?
Recommended by ECCO, NICE, and AGA guidelines, calprotectin is an early detector of inflammation, differentiates IBD from IBS, and provides objective diagnostic and prognostic information. By enabling sub‑clinical detection of flare, early intervention, and close‑to‑real‑time mucosal healing assessment, calprotectin testing can support both immediate clinical decisions and long‑term disease management.
Who we are
Global Specialists Dedicated to Advancing Calprotectin in IBD Care
Calpro is a Norwegian biotechnology company focused exclusively on calprotectin, the leading non-invasive biomarker for intestinal inflammation. We develop, manufacture, and distribute solutions to help clinicians and patients make timely decisions and support prognostic assessment.
Hospitals, laboratories, clinicians, and patients rely on Calpro’s portfolio, which includes the CalproSmart® Self-Test, CalproLab® ELISA kits, and Calpro® Easy Extract sample preparation, to support early detection of inflammation and effective monitoring of disease progression.
Get Calprotectin Research, Webinars, and Event Alerts
Latest News & Events
-
IBD Awareness Day: Monitoring Is Where It Matters
Every year on May 19, World IBD Day brings attention to the reality of living with Crohn’s disease and ulcerative colitis. More than ten million people worldwide manage these conditions every day, navigating flares, treatment decisions, and the uncertainty of a disease with no cure. Awareness matters. But for clinicians treating IBD, awareness is not…
-
Comparing CalproSmart to its lab-based counterpart CalproLab for monitoring in IBD
Fecal calprotectin (fCal) is an essential biomarker for monitoring inflammatory bowel disease (IBD), helping ensure patients receive the right treatment at the right time. As patient-centered care grows, remote monitoring tools like the CalproSmart self-test offer an efficient alternative to traditional lab-based methods. But do these two different analyses give the same fCal results? This…
-
Groundbreaking achievement to improve IBD patient care by remote monitoring
In this case study, we get insights from MUDr. Karin Černá, from the ISCARE Clinic in the Czech Republic. The clinic has a distance care service aiming for improved remote care of Inflammatory Bowel Diseases (IBD). As of the beginning of 2022 in the Czech Republic, remote care for patients diagnosed with IBD is covered by public…